Methods and materials for treating a stroke
AssigneesUniversity of Pittsburgh—Of the Commonwealth System of Higher Education, The United States Government as represented by the Department of Veterans Affairs
InventorsXiaoming Hu, Jun Chen, Lawrence R. Wechsler, Yejie Shi
Life of this patent
Estimating the term…
Abstract
This document relates to methods and materials involved in treating stroke. For example, nanoparticles (e.g., polymer-coated nanoparticles) designed to deliver two or more poly peptides that are normally secreted from mesenchymal stem cells (MSCs; e.g., MSCs of a human less than 33 years of age)) to the brain are provided as well as methods for using such nanoparticles to treat a mammal (e.g., a human) having or having had a stroke.
Claims19
A composition comprising two or more populations of nanoparticles, wherein each population of nanoparticles independently comprises a polypeptide selected from the group consisting of a IL-4 polypeptide, a IL-10 polypeptide, a TGFß polypeptide, a IGF1 polypeptide, a draxin polypeptide, a NPTX2 polypeptide, a PTN polypeptide, a TGFB3 polypeptide, a PRXL2A polypeptide, a MMP13 polypeptide, a MMP9 polypeptide, and a ADAM22 polypeptide.
A composition comprising a plurality of nanoparticles, wherein each nanoparticle comprises at least two polypeptides selected from the group consisting of a IL-4 polypeptide, a IL-10 polypeptide, a TGFß polypeptide, a IGF1 polypeptide, a draxin polypeptide, a NPTX2 polypeptide, a PTN polypeptide, a TGFB3 polypeptide, a PRXL2A polypeptide, a MMP13 polypeptide, a MMP9 polypeptide, and a ADAM22 polypeptide.
Dependencies are inferred from the claim text.